
J&J thought it could evade the anti-kickback statute because it signed an agreement that didn’t directly involve sales of Risperdal. The judge, however, said that contract was merely a “subterfuge” to disguise kickbacks meant to encourage the prescribing of Risperdal.
Full Article and Source:
JNJ May Be Liable for Antipsychotic Kickback Scheme
3 comments:
May be? I bet it's a lot more than may be!
Follow the money!
Big pharma is as powerful as the legal community.
Post a Comment